|
Online edition of India's National Newspaper Thursday, October 18, 2001 |
|
Front Page |
National |
Southern States |
Other States |
International |
Opinion |
Business |
Sport |
Science & Tech |
Entertainment |
Miscellaneous |
Features |
Classifieds |
Employment |
Index |
Home |
|
Science & Tech
| Previous
| Next
Early detection crucial to treat rheumatoid arthritis
ARTHRITIS OF the knee afflicting the old and obese people
(osteoarthritis) is a common form of disease. Yet it is not the
only form of arthritis that is prevalent in India. But sadly any
pain in the joints is often wrongly diagnosed as arthritis
afflicting the old. And herein lies a big problem.
Nearly seven million people in India suffer from a form of
arthritis the rheumatoid arthritis - that initially affects the
small joints. Yet due to lack of awareness even among the medical
fraternity has led to a situation where these patients are being
treated like an osteoarthiritic patient.
Rheumatoid arthritis unlike osteoarthritis is not the result of
wear and tear of the cartilage or other tissues surrounding the
bone.
The synovium found in the bone is a joint lining membrane which
surrounds the joint cavity. It produces the fluid that lubricates
the joint for smooth movement. In the case of rheumatoid
arthritis the synovium becomes inflamed and thickened and
produces large amount of fluid.
This increased amount of fluid causes swelling, stiffness and
pain. At a chronic stage the thickened and inflamed membrane
releases proteins that damage the bone and cartilage. The bone
damage in turn results in joint damage, instability and
deformity.
"Hence wrong diagnosis can lead to serious problems as the
patients can end up with irreversible disability and deformity,"
said Dr. S. Mukherjee, President of the Indian Rheumatology
Association. "It is an autoimmune disease where the immune system
affects the healthy body tissues.
Hence no system of medicine can cure rheumatoid arthritis." The
cause of disease is not known. The disease can also reduce the
life span by a few years and in some cases can prove fatal if not
treated properly.
Though a cure for rheumatoid arthritics has not been found, early
detection and medication can prevent progression of the disease.
Early detection becomes paramount as deformity and disability can
set in as early as six weeks from the onset on the disease.
Wrong diagnosis can be easily prevented as rheumatoid arthritis
shows certain unique symptoms. For one, it mostly affects the
wrists and the joints of the fingers and feet first and then
spreads to other joints unlike osteoarthritis that affects the
big joints like the knees and hip.
Also, multiple joints are affected in a symmetrical pattern like
- inflammation on both the wrists and/or fingers of the hand.
Joint stiffness in the mornings is a noticeable symptom.
In children rheumatoid arthritis is n mistaken for rheumatic
arthritis. Rheumatic arthritis as a rule attacks only the big
joint like the knee and it always has a triggering mechanism
(streptococcus infection) causing rheumatic fever with sore
throat. Triggering mechanism is not yet known in rheumatoid
arthritis though the gene has been identified.
Females are more affected than males. "The ratio is 3:1. And one
very important observation has been that the number of females
affected prior to menarche and after menopause are less and
almost the same as males," said Dr. Mukherjee. Also, pregnant
women suffer less pain.
A strong hypothesis is that female hormone has a role to play in
women.
Wrong diagnose is not the only problem that confronts the
disease. Choice of medicines to treat rheumatoid arthritis has
also been found wanting. But the world arthritis day celebrated
on October 12 has brought cheer to the patients. Mumbai based
Aventis Pharma Ltd had launched a drug Arava (leflunomide) to
treat the disease.
According to Dr. A.N. Malaviya, consultant Rheumatologist in New
Delhi and considered as a the father in Rheumatology, Arava is a
very good disease-modifying drug for rheumatoid arthritis. "It
helps slow down the disease progression," said Mr. B. Ahmed,
Executive Director (Commercial operations) Aventis Pahrma Ltd.
The early onset of response and sustained benefit are the other
benefits of the drug. The medicine has been launched in India
only three years after its introduction in the U.S. Arava has
been found to affect the foetus if taken by pregnant women. Hence
judicious use of the drug becomes mandatory.
R. Prasad
in Chennai
Send this article to Friends by E-Mail
|
|
Section : Science & Tech Previous : Nobel Laureates in chemistry: Down memory lane Next : Stem cells hold key to blood development | |
|
Front Page |
National |
Southern States |
Other States |
International |
Opinion |
Business |
Sport |
Science & Tech |
Entertainment |
Miscellaneous |
Features |
Classifieds |
Employment |
Index |
Home | |
|
Copyright © 2001 The Hindu Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu |
|